Epigenomics to Launch Epi proColon in Israel with Marketing Partner Pronto Diagnostics

Starting in November, Pronto Diagnostics plans to begin marketing in Israel Epigenomics' Septin 9-based test for early detection of colorectal cancer

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories